89bio shares are trading higher after UBS initiated coverage on the stock with a Buy rating and announced a $36 price target.
Portfolio Pulse from Benzinga Newsdesk
UBS has initiated coverage on 89bio with a Buy rating and a price target of $36. This has led to an increase in the trading of 89bio shares.
August 28, 2023 | 2:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
89bio's stock, symbolized as ETNB, is expected to see increased trading and potentially higher prices due to UBS's Buy rating and $36 price target.
UBS's initiation of coverage on 89bio with a Buy rating and a price target of $36 is a strong positive signal for investors. This is likely to increase demand for the stock, leading to higher trading volumes and potentially higher prices in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100